TABLE OF CONTENTS
Volume 23, Issue 52 (4 November 2004)
Commentary
The regulation of CHK2 in human cancer FREE
Ashley L Craig and Ted R Hupp
Oncogene 23: 8411-8418; advance online publication, September 13, 2004; doi:10.1038/sj.onc.1208035
Original Papers
Depletion of physiological levels of the human TID1 protein renders cancer cell lines resistant to apoptosis mediated by multiple exogenous stimuli FREE
Kirsten M Edwards and Karl Münger
Oncogene 23: 8419-8431; advance online publication, May 24, 2004; doi:10.1038/sj.onc.1207732
The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis FREE
Rodolfo Iuliano, Ilaria Le Pera, Carmela Cristofaro, Francesco Baudi, Franco Arturi, PierLorenzo Pallante, Maria Luisa Martelli, Francesco Trapasso, Lorenzo Chiariotti and Alfredo Fusco
Oncogene 23: 8432-8438; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207766
Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line FREE
Andrea Cavazzoni, Pier Giorgio Petronini, Maricla Galetti, Luca Roz, Francesca Andriani, Paolo Carbognani, Michele Rusca, Claudia Fumarola, Roberta Alfieri and Gabriella Sozzi
Oncogene 23: 8439-8446; advance online publication, September 13, 2004; doi:10.1038/sj.onc.1207847
Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression FREE
Rong Rong, Ezequiel I Surace, Carrie A Haipek, David H Gutmann and Keqiang Ye
Oncogene 23: 8447-8454; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207794
Transformation fingerprint: induced STAT3-C, v-Src and Ha-Ras cause small initial changes but similar established profiles in mRNA FREE
Keren Paz, Nicholas D Socci, Erik van Nimwegen, Agnes Viale and James E Darnell
Oncogene 23: 8455-8463; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207803
RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells FREE
Xiang-Ming Xu, Da Wang, Qi Shen, Yi-Qing Chen and Ming-Hai Wang
Oncogene 23: 8464-8474; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207907
Autocrine stimulation of rhadinovirus-transformed T cells by the chemokine CCL1/I-309 FREE
Gültekin Tamgüney, Jacques Van Snick and Helmut Fickenscher
Oncogene 23: 8475-8485; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207903
RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas FREE
Christopher S Gondi, Sajani S Lakka, Dzung H Dinh, William C Olivero, Meena Gujrati and Jasti S Rao
Oncogene 23: 8486-8496; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207879
Involvement of p53 and Fas/CD95 in murine neural progenitor cell response to ionizing irradiation FREE
Alexandra Semont, Ewa B Nowak, Céline Silva Lages, Céline Mathieu, Marc-André Mouthon, Evelyne May, Isabelle Allemand, Pascal Millet and François D Boussin
Oncogene 23: 8497-8508; advance online publication, September 13, 2004; doi:10.1038/sj.onc.1207821
Loss of E-cadherin leads to upregulation of NF
B activity in malignant melanoma FREE
S Kuphal, I Poser, C Jobin, C Hellerbrand and A K Bosserhoff
Oncogene 23: 8509-8519; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207831
DKK1, a negative regulator of Wnt signaling, is a target of the 
-catenin/TCF pathway FREE
Atsushi Niida, Takatoshi Hiroko, Mana Kasai, Yoichi Furukawa, Yusuke Nakamura, Yutaka Suzuki, Sumio Sugano and Tetsu Akiyama
Oncogene 23: 8520-8526; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207892
Loss of c-abl facilitates anchorage-independent growth of p53- and RB- deficient primary mouse embryonic fibroblasts FREE
Jun Suzuki, Taiko Sukezane, Tsuyoshi Akagi, Maria Magdalena Georgescu, Mayumi Ohtani, Hirokazu Inoue, Parmjit S Jat, Stephen P Goff, Hidesaburo Hanafusa and Tomoyuki Shishido
Oncogene 23: 8527-8534; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207894
Alternative splicing and mutation status of CHEK2 in stage III breast cancer FREE
Vidar Staalesen, Jacob Falck, Stephanie Geisler, Jirina Bartkova, Anne-Lise Børresen-Dale, Jiri Lukas, Johan Richard Lillehaug, Jiri Bartek and Per Eystein Lønning
Oncogene 23: 8535-8544; advance online publication, September 13, 2004; doi:10.1038/sj.onc.1207928
Short Reports
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer FREE
Jirina Bartkova, Per Guldberg, Kirsten Grønbæk, Karen Koed, Hanne Primdahl, Klaus Møller, Jiri Lukas, Torben F Ørntoft and Jiri Bartek
Oncogene 23: 8545-8551; advance online publication, September 13, 2004; doi:10.1038/sj.onc.1207878
Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors FREE
Yukinari Kato, Isoji Sasagawa, Mika Kaneko, Motoki Osawa, Naoya Fujita and Takashi Tsuruo
Oncogene 23: 8552-8556; advance online publication, September 13, 2004; doi:10.1038/sj.onc.1207869
Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells FREE
Nathan R Treff, Gregory A Dement, Jennifer E Adair, Rachel L Britt, Rong Nie, James E Shima, Wayne E Taylor and Raymond Reeves
Oncogene 23: 8557-8562; advance online publication, September 20, 2004; doi:10.1038/sj.onc.1207926
